Publication


Featured researches published by Ichiro Mashima.


General Hospital Psychiatry | 2018

Performance of the Japanese version of the Patient Health Questionnaire-9 (J-PHQ-9) for depression in primary care

Kumiko Muramatsu; Hitoshi Miyaoka; Kunitoshi Kamijima; Yoshiyuki Muramatsu; Yutaka Tanaka; Michio Hosaka; Yusuke Miwa; Katsuya Fuse; Fumitoshi Yoshimine; Ichiro Mashima; Natsue Shimizu; Hiroto Ito; Eiji Shimizu

OBJECTIVE To assess the performance of the Japanese version of the Patient Health Questionnaire-9 (J-PHQ-9) for depression in primary care. METHODS Participants in both phases completed the J-PHQ-9, while patients in the second phase also completed the SF-8 (the short form for the health-related QOL scale SF-36). Subjects (n = 284; male = 107, female = 177) had to return the questionnaires to their health care professional within 48 hours and undergo a diagnostic evaluation interview based on the Japanese version of M.I.N.I-Plus. RESULTS 93 patients were diagnosed as having major depressive disorder (MDD). In the J-PHQ-9, the optimal cutpoint ≥ 10 had sensitivity of 90.5% and specificity of 76.6%. As for the categorical algorithms, the sensitivity was 80.6%; specificity was 89.5%, and a positive likelihood ratio of 7.7. The Stratum-specific likelihood ratios (SSLRs) of the J-PHQ-9 scores of 0-9, 10-14, 15-19, and 20-27 for major depression were 0.10 (95% CI: 0.05-0.20), 1.67 (95% CI: 1.02-2.76), 5.41 (95% CI: 2.87-10.22), and 11.98 (95% CI: 5.39-26.63), respectively. The relationship between the severity of J-PHQ-9 and the MCS of SF-8 was significant (χ 2 = 85.72, df = 4, P ≤ 0.0001). CONCLUSIONS This study has validated the J-PHQ-9 as a useful tool for the assessment of MDD in primary care in Japan.


Internal Medicine | 2018

A Cluster Analysis of Bronchial Asthma Patients with Depressive Symptoms

Yo Seino; Takashi Hasegawa; Toshiyuki Koya; Takuro Sakagami; Ichiro Mashima; Natsue Shimizu; Yoshiyuki Muramatsu; Kumiko Muramatsu; Eiichi Suzuki; Toshiaki Kikuchi

Objective Whether or not depression affects the control or severity of asthma is unclear. We performed a cluster analysis of asthma patients with depressive symptoms to clarify their characteristics. Methods Multiple medical institutions in Niigata Prefecture, Japan, were surveyed in 2014. We recorded the age, disease duration, body mass index (BMI), medications, and surveyed asthma control status and severity, as well as depressive symptoms and adherence to treatment using questionnaires. A hierarchical cluster analysis was performed on the group of patients assessed as having depression. Results Of 2,273 patients, 128 were assessed as being positive for depressive symptoms [DS(+)]. Thirty-three were excluded because of missing data, and the remaining 95 DS[+] patients were classified into 3 clusters (A, B, and C). The patients in cluster A (n=19) were elderly, had severe, poorly controlled asthma, and demonstrated possible adherence barriers; those in cluster B (n=26) were elderly with a low BMI and had no significant adherence barriers but had severe, poorly controlled asthma; and those in cluster C (n=50) were younger, with a high BMI, no significant adherence barriers, well-controlled asthma, and few were severely affected. The scores for depressive symptoms were not significantly different between clusters. Conclusion About half of the patients in the DS[+] group had severe, poorly controlled asthma, and these clusters were able to be distinguished by their Adherence Starts with Knowledge (ASK)-12 score, which reflects adherence barriers. The control status and severity of asthma may also be related to the age, disease duration, and BMI in the DS[+] group.


Allergology International | 2004

Questionnaire‐based analysis of the current level of asthma control and management in Niigata Prefecture, Japan: Changes from 1998 to 2000

Takashi Hasegawa; Eiichi Suzuki; Yoshiyuki Muramatsu; Toshiyuki Koya; Ichiro Mashima; Ariyoshi Kondåoh; Hirofumi Takagi; Katsuya Fujimori; Masaaki Arakawa; Hirohisa Yoshizawa; Fumitake Gejyo


Allergology International | 2002

Questionnaire-based characterization of bronchial asthma in the elderly: Analysis in Niigata Prefecture, Japan

Eiichi Suzuki; Takashi Hasegawa; Toshiyuki Koya; Ichiro Mashima; Yoshiyuki Muramatsu; Ariyoshi Kondo; Masaaki Arakawa; Fumitake Gejyo


Internal Medicine | 2000

Malignant peritoneal mesothelioma associated with deep vein thrombosis following radiotherapy for seminoma of the testis

Fuminori Sato; Hajime Yamazaki; Ken Ataka; Ichiro Mashima; Kenta Suzuki; Toru Takahashi; Hajime Umezu; Fumitake Gejyo


Journal of Smooth Muscle Research | 2009

Electrogastrographic responses to the stress of a mirror drawing test in outpatients consulting a psychosomatic clinic

Shinji Homma; Ichiro Mashima; Yoshiyuki Muramatsu; Fumitake Gejyo


新潟青陵大学大学院臨床心理学研究 | 2014

精神疾患簡易構造化面接法the M.I.N.I-International Neuropsychiatric Interviewを用いた口腔顔面痛患者の初診時の精神医学的診断評価の試み

裕 田中; 公美子 村松; 芳幸 村松; 一郎 真島; 健夫 藤村; 夏恵 清水; 洋 清野; 文俊 吉嶺; 浩治 櫻井; 憲司 瀬尾; 等 宮岡; Yutaka Tanaka; Kumiko Muramatsu; Yoshiyuki Muramatsu; Ichiro Mashima; Takeko Fujimura; Natsue Shimizu; Hiroshi Seino; Fumitoshi Yoshimine; Koji Sakurai; Kenji Seo; Hitoshi Miyaoka


american thoracic society international conference | 2010

Analyses Of Depression In Patient With Bronchial Asthma By The PHQ-9

Fumitoshi Yoshimine; Takashi Hasegawa; Yoshiyuki Muramatsu; Kumiko Muramatsu; Toshiyuki Koya; Ichiro Mashima; Masaaki Arakawa; Fumitake Gejyo; Eiichi Suzuki


Acta medica et biologica | 2008

Depression and anxiety associated with KDQOL in Japan according to a dialysis patient's length of time on dialysis

Natsue Shimizu; Yoshiyuki Muramatsu; Shuichi Murakami; Ichiro Mashima; Shinichi Nishi; Masaaki Arakawa; Fumitake Gejyo; Koji Sakurai


Niigata medical journal | 2004

1 Headache in Psychosomatic Medicine (Headache in Various Clinical Fields)

Natsue Sasaki; Ichiro Mashima; Fumitake Gejyo; Atsuko Katagiri; Yoshiyuki Muramatsu

Researchain Logo
Decentralizing Knowledge